Pms-repaglinide 0.5, 1, 2 Mg (2017-04-18)

Recall Summary PMS-Repaglinide tablets in 0.5 mg, 1 mg, and 2 mg strengths are being recalled across Canada due to a product safety issue. This medication is used to help control blood sugar in people with type 2 diabetes. The recall affects all patients in Canada who have this product.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-06-22

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/247cbd0d-894d-49a3-915e-d449be79eb2a